FOR EDUCATIONAL & RESEARCH PURPOSES ONLY - NOT FOR HUMAN CONSUMPTION - NOT MEDICAL ADVICE
PeptaBase
Category Authority

GH Secretagogues: Research Overview

Growth hormone secretagogues are studied for pituitary signaling, pulsatile GH release, IGF-1 modulation, and protocol timing research.

What Are GH Secretagogues

Growth hormone secretagogues are peptides and related compounds studied for their ability to influence growth-hormone release through pituitary or ghrelin-related signaling pathways. In research discussions, this category commonly includes GHRH analogs, ghrelin receptor agonists, and compounds often paired together in protocol planning. PeptaBase treats them as a distinct authority group because the literature often compares these peptides by pulse timing, half-life, receptor pathway, and downstream IGF-1 logic rather than by headline use case alone.

Mechanisms Studied

Mechanisms studied here typically center on pulsatile GH release, GHRH signaling, ghrelin-receptor agonism, downstream IGF-1 modulation, recovery-related endocrine effects, and timing-sensitive pharmacodynamic behavior. A peptide may look similar to another on the surface, yet act through a meaningfully different upstream pathway. Structured category context helps clarify those differences, especially when one compound is researched for prolonged stimulation and another is studied more for short-acting secretagogue behavior or protocol stacking logic.

Common Compounds

Common compounds in this category include CJC-1295, Ipamorelin, Sermorelin, Hexarelin, GHRP-2, GHRP-6, MK-677, and Tesamorelin. Some have clinical or marketed contexts, while others remain more strongly associated with experimental or protocol-focused research. Because these compounds are frequently mentioned together, category-level authority content is useful for separating receptor pathway, administration cadence, and study maturity from the simplified way secretagogues are often described elsewhere online.

Research Evidence

The evidence base across GH secretagogues is varied. Some compounds have formal clinical history and better characterized pharmacology, while others are cited more through research use, protocol communities, or narrower study sets. PeptaBase presents this category with evidence labels, species context, and internal links to each peptide page so readers can move from the broader secretagogue framework into the specific compound literature with better context and less overgeneralization.

Peptides in This Category

CJC without DAC (MOD-GRF)
CJC-1295 DAC
GHRP-2
GHRP-6
Hexarelin
Ipamorelin
MK-677
Sermorelin
Tesamorelin